Wu, Jingsong
He, Youze
Liang, Shengxiang
Liu, Zhizhen
Huang, Jia
Liu, Weilin
Tao, Jing
Chen, Lidian
Chan, Chetwyn C. H.
Lee, Tatia M. C.
Funding for this research was provided by:
Central Government Guided Local Science and Technology Development Project (2020L3013)
Article History
Received: 26 June 2022
Accepted: 21 August 2023
First Online: 23 September 2023
Declarations
:
: This trial was registered in the Chinese Clinical Trial Registry on June 2020 (Registration Number: ChiCTR2000034012) and approved by the Ethics Committees of Affiliated Rehabilitation Hospital, Affiliated People’s Hospital, and Affiliated Second Hospital of Fujian University of Traditional Chinese Medicine (FJTCM). The approved numbers were as follows: 2020QX-001–02, 2020–054-02, and SPHFJP-L2020001-02, respectively. In this study, we provided detailed explanations of the purpose and procedures of this trial, and written informed consent was obtained from all participants.
: Not applicable.
: Chetwyn C.H. Chan and Tatia M.C. Lee are honorary research consultants of Amity Brain Health and A.I. Technology Co. Ltd. The other authors declared that there were no conflicts of interest.